Patents by Inventor Frederick Meins

Frederick Meins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070184464
    Abstract: The invention is based in part on the generation of a double stranded RNA molecule substantially covering the whole transcribed region of a gene, and cleaving this using an RNA endonuclease to generate small RNA molecules which are already or may be subsequently labelled. The invention provides small labelled ribonucleic acid (RNA) fragments for use as probes to detect potentially small interfering ribonucleic acid (siRNA) fragments produced in vivo. The invention also provides uses of said small labelled RNA fragments and kits suitable for preparing said small labelled RNA fragments.
    Type: Application
    Filed: October 12, 2006
    Publication date: August 9, 2007
    Inventors: Azeddine Si-Ammour, Todd Blevins, Frederick Meins
  • Publication number: 20060090218
    Abstract: The present invention relates to methods to regulate gene expression in plants. In particular, manipulation of the expression in a plant cell of a nucleotide sequence encoding a polypeptide comprising a 3?-5? exonuclease domain is disclosed. More stable and predictable expression is thus obtained. The present invention also relates to method of increasing or decreasing post-transcriptional silencing. The invention further relates to novel nucleic acid molecules comprising nucleotide sequences encoding polypeptides comprising a 3?-5? exonuclease domain.
    Type: Application
    Filed: December 13, 2005
    Publication date: April 27, 2006
    Inventors: Joshua Levin, Kenneth Phillips, Gregory Budziszewski, Frederick Meins, Evgueni Glazov
  • Publication number: 20060057590
    Abstract: The invention is based in part on the generation of a double stranded RNA molecule substantially covering the whole transcribed region of a gene, and cleaving this using an RNA endonuclease to generate small RNA molecules which are already or may be subsequently labelled. The invention provides small labelled ribonucleic acid (RNA) fragments for use as probes to detect potentially small interfering ribonucleic acid (siRNA) fragments produced in vivo. The invention also provides uses of said small labelled RNA fragments and kits suitable for preparing said small labelled RNA fragments.
    Type: Application
    Filed: September 14, 2004
    Publication date: March 16, 2006
    Inventors: Azeddine Si-Ammour, Todd Blevins, Frederick Meins
  • Publication number: 20050042752
    Abstract: The present invention relates to methods of regulating gene expression in eukaryotic cells, in particular providing stable and persistent expression that can undergo systemic spreading in plants.
    Type: Application
    Filed: September 27, 2002
    Publication date: February 24, 2005
    Inventors: Patrice Crete, Ulrich Klahre, Frederick Meins
  • Patent number: 6632981
    Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5′ region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.
    Type: Grant
    Filed: July 16, 2001
    Date of Patent: October 14, 2003
    Assignee: Novartis Finance Corporation
    Inventors: Frederick Meins, Jr., Hideaki Shinshi, Herman C. Wenzler, Jan Hofsteenge, John A. Ryals, Christoph Sperisen
  • Publication number: 20030166227
    Abstract: The present invention relates to methods to regulate gene expression in plants. In particular, manipulation of the expression in a plant cell of a nucleotide sequence encoding a polypeptide comprising a 3′-5′ exonuclease domain is disclosed. More stable and predictable expression is thus obtained. The present invention also relates to method of increasing or decreasing post-transcriptional silencing. The invention further relates to novel nucleic acid molecules comprising nucleotide sequences encoding polypeptides comprising a 3′-5′ exonuclease domain.
    Type: Application
    Filed: June 29, 2001
    Publication date: September 4, 2003
    Inventors: Joshua Levin, Kenneth Phillips, Gregory Budziszewski, Frederick Meins, Evgueni A. Glazov
  • Patent number: 6262342
    Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5′ region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: July 17, 2001
    Assignee: Novartis Finance Corporation
    Inventors: Frederick Meins, Jr., Hideaki Shinshi, Herman C. Wenzler, Jan Hofsteenge, John A. Ryals, Christoph Sperisen